義大醫院內科部部長

學術論文著作

1. 1. Lo CC, Huang CF, Cheng PN, Tseng KC, Chen CY, Kuo HT, Huang YH, Tai CM, Peng CY, Bair MJ, Chen CH, Yeh ML, Lin CL, Lin CY, Lee PL, Chong LW, Hung CH, Chang TS, Huang JF, Yang CC, Hu JT, Lin CW, Chen CT, Wang CC, Su WW, Hsieh TY, Lin CL, Tsai WL, Lee TH, Chen GY, Wang SJ, Chang CC, Mo LR, Yang SS, Wu WC, Huang CS, Hsiung CK, Kao CN, Tsai PC, Liu CH, Lee MH, Liu CJ, Dai CY, Chuang WL, Lin HC, Kao JH, Yu ML; TACR investigators .Ledipasvir/sofosbuvir for HCV genotype 1, 2, 4-6 infection: Real-world evidence from a nationwide registry in Taiwan. J Formos Med Assoc. [Epub ahead of print] (SCI)
   2. Cheng PN, Mo LR, Chen CT, Chen CY, Huang CF, Kuo HT, Lo CC, Tseng KC, Huang YH, Tai CM, Peng CY, Bair MJ, Chen CH, Yeh ML, Lin CL, Lin CY, Lee PL, Chong LW, Hung CH, Chang TS, Huang JF, Yang CC, Hu JT, Lin CW, Wang CC, Su WW, Hsieh TY, Lin CL, Tsai WL, Lee TH, Chen GY, Wang SJ, Chang CC, Yang SS, Wu WC, Huang CS, Chou KH, Kao CN, Tsai PC, Liu CH, Lee MH, Cheng CY, Tsai MC, Liu CJ, Dai CY, Lin HC, Kao JH, Chuang WL, Yu ML; TACR investigators. Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan. Infect Dis Ther. 2022;11(1):485-500. (SCI)
   3. Huang CF, Kuo HT, Chang TS, Lo CC, Hung CH, Huang CW, Chong LW, Cheng PN, Yeh ML, Peng CY, Cheng CY, Huang JF, Bair MJ, Lin CL, Yang CC, Wang SJ, Hsieh TY, Lee TH, Lee PL, Wu WC, Lin CL, Su WW, Yang SS, Wang CC, Hu JT, Mo LR, Chen CT, Huang YH, Chang CC, Huang CS, Chen GY, Kao CN, Tai CM, Liu CJ, Lee MH, Tsai PC, Dai CY, Kao JH, Lin HC, Chuang WL, Chen CY, Tseng KC, Yu ML. Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan. Sci Rep. 2021;11(1):23473.
   4. Yeh ML, Hung CH, Tseng KC, Lai HC, Chen CY, Kuo HT, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, Lo GH, Tai CM, Lin CW, Kao JH, Liu CH, Yan SL, Bair MJ, Lin CY, Su WW, Chu CH, Chen CJ, Tung SY, Lo CC, Cheng PN, Chiu YC, Wang CC, Cheng JS, Tsai WL, Lin HC, Huang YH, Huang CF, Huang JF, Dai CY, Chuang WL, Tsai PC, Peng CY, Liu CJ, Yu ML. Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH). Hepatol Int. 2021 ;15(5):1109-1121. (SCI)
   5. Hsu MH, Wang WL, Chen TH, Tai CM, Wang HP, Lee CT. Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell carcinoma in Taiwan. BMC Gastroenterol. 2021;21(1):308. (SCI)
   6. Huang CF, Tseng KC, Cheng PN, Hung CH, Lo CC, Peng CY, Bair MJ, Yeh ML, Chen CH, Lee PL, Lin CY, Kuo HT, Chen CT, Yang CC, Huang JF, Tai CM, Hu JT, Lin CL, Su WW, Tsai WL, Huang YH, Cheng CY, Lin CL, Wang CC, Yang SS, Mo LR, Chen GY, Chang CC, Wang SJ, Huang CS, Hsieh TY, Lin CW, Lee TH, Chong LW, Huang CW, Chang SN, Tsai MC, Hsu SJ, Kao JH, Liu CJ, Liu CH, Lin HC, Lee MH, Tsai PC, Dai CY, Chuang WL, Chen CY, Yu ML. Impact of Sofosbuvir-Based Direct-Acting Antivirals on Renal Function in Chronic Hepatitis C Patients With Impaired Renal Function: A Large Cohort Study From the Nationwide HCV Registry Program (TACR). Clin Gastroenterol Hepatol. 2021 Jul 30 [Epub ahead of print] (SCI)
   7. Hsu WF, Tsai PC, Chen CY, Tseng KC, Lai HC, Kuo HT, Hung CH, Tung SY, Wang JH, Chen JJ, Lee PL, Chien RN, Lin CY, Yang CC, Lo GH, Tai CM, Lin CW, Kao JH, Liu CJ, Liu CH, Yan SL, Bair MJ, Su WW, Chu CH, Chen CJ, Lo CC, Cheng PN, Chiu YC, Wang CC, Cheng JS, Tsai WL, Lin HC, Huang YH, Huang JF, Dai CY, Chuang WL, Yu ML, Peng CY. Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort). J Gastroenterol Hepatol. 2021 ;36(10):2884-2892. (SCI)
   8. Chen WH, Chen IS, Chen TH, Hsu MH, Tsai YN, Tai CM (correspondence). Endoscopic balloon dilation for gastrojejunal anastomotic stricture after Roux-en-Y gastric bypass: a case series. Advances in Digestive Medicine 2021(Accepted).
   9. Hsieh MH, Bair MJ, Tsai PC, Tseng KC, Lo CC, Chen CY, Kuo HT, Hung CH, Lai HC, Peng CY, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, Lo GH, Kao JH, Liu CJ, Liu CH, Yan SL, Lin CY, Su WW, Chu CH, Chen CJ, Tung SY, Tai CM, Lin CW, Cheng PN, Chiu YC, Wang CC, Cheng JS, Tsai WL, Lin HC, Huang YH, Yeh ML, Huang CF, Huang JF, Dai CY, Yu ML, Chuang WL; T-COACH investigators. Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan. J Gastroenterol Hepatol. 2021 ;36(8):2247-2254. (SCI)
   10. Chen CY, Huang CF, Cheng PN, Tseng KC, Lo CC, Kuo HT, Huang YH, Tai CM, Peng CY, Bair MJ, Chen CH, Yeh ML, Lin CL, Lin CY, Lee PL, Chong LW, Hung CH, Huang JF, Yang CC, Hu JT, Lin CW, Chen CT, Wang CC, Su WW, Hsieh TY, Lin CL, Tsai WL, Lee TH, Chen GY, Wang SJ, Chang CC, Mo LR, Yang SS, Wu WC, Huang CS, Hsiung CK, Kao CN, Tsai PC, Liu CH, Lee MH, Liu CJ, Dai CY, Kao JH, Chuang WL, Lin HC, Yu ML. Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan. Liver Int. 2021 ;41(6):1265-1277 (SCI)
   11. Hsu YC, Chen CY, Chang IW, Chang CY, Wu CY, Lee TY, Wu MS, Bair MJ, Chen JJ, Chen CC, Tseng CH, Tai CM, Huang YT, Ku WH, Mo LR, Lin JT. Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial. Lancet Infect Dis. 2021;21(6):823-833. (SCI)
   12. Tseng CM, Wang HH, Wang WL, Lee CT, Tai CM, Tseng CH, Chen CC, Tsai YN, Sun MS, Hsu YC. Prognostic impact of diabetes mellitus on overall survival in a nationwide population-based cohort of patients with pancreatic cancer. Endocr Pract. 2020;26(7):707-713. (SCI)
   13. Tsai PC, Chen CY, Kuo HT, Hung CH, Tseng KC, Lai HC, Peng CY, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, Lo GH, Kao JH, Liu CJ, Liu CH, Yan SL, Bair MJ, Lin CY, Su WW, Chu CH, Chen CJ, Tung SY, Tai CM, Lin CW, Lo CC, Cheng PN, Chiu YC, Wang CC, Cheng JS, Tsai WL, Lin HC, Huang YH, Yeh ML, Huang CF, Hsieh MH, Huang JF, Dai CY, Chung WL, Ke CK, Yu ML. Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH). Open Forum Infect Dis. 2020 ;7(10):ofaa397. (SCI)
   14. Huang CF, Lai HC, Chen CY, Tseng KC, Kuo HT, Hung CH, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, Lo GH, Tai CM, Lin CW, Kao JH, Liu CJ, Liu CH, Yan SL, Bair MJ, Lin CY, Su WW, Chu CH, Chen CJ, Tung SY, Lo CC, Cheng PN, Chiu YC, Wang CC, Cheng JS, Tsai WL, Lin HC, Huang YH, Yeh ML, Huang JF, Dai CY, Chuang WL, Tsai PC, Peng CY, Yu ML Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).Am J Gastroenterol. 2020 ;115(8):1226-1235. (SCI)
   15. Lo GH, Lin CW, Tai CM, Perng DS, Chen IL, Yeh JH, Lin HC. A prospective, randomized trial of thrombin versus cyanoacrylate injection in the control of acute gastric variceal hemorrhage. Endoscopy. 2020; 52(7):548-555 (SCI)
   16. Chang CW, Tu CH, Chou JW, Huang TY, Hsu WH, Wang YP, Chen CC, Chung CS, Lin CP, Lin WC, Tai CM, Wang HY, Chen MJ. Endoscopic management of strictures in patients with Crohn's disease - A multi-center experience in Taiwan. J Formos Med Assoc. 2020;119(10):1500-1505. (SCI)
   17. Wang WL, Chang IW, Hsu MH, Chen TH, Tseng CM, Tseng CH, Tai CM, Wang HP, Lee CT. Risk factors and pathological characteristics for intraductal tumor spread of submucosal gland in early esophageal squamous cell neoplasia. Sci Rep. 2020;10(1):6860. (SCI)
   18. Hsu WF, Chen CY, Tseng KC, Lai HC, Kuo HT, Hung CH, Tung SY, Wang JH, Chen JJ, Lee PL, Chien RN, Lin CY, Yang CC, Lo GH, Tai CM, Lin CW, Kao JH, Liu CJ, Liu CH, Yan SL, Bair MJ, Su WW, Chu CH, Chen CJ, Lo CC, Cheng PN, Chiu YC, Wang CC, Cheng JS, Tsai WL, Lin HC, Huang YH, Tsai PC, Huang JF, Dai CY, Chuang WL, Yu ML, Peng CY. Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritis. Sci Rep. 2020;10(1):5372. (SCI)
   19. Tseng CM, Wang HH, Lee CT, Tai CM, Tseng CH, Chen CC, Tsai YN, Chen TH, Hsu MH, Wang CC, Hwang TZ, Wang HP, Wang WL. A nationwide population-based study to access the risk of metachronous esophageal cancers in head and neck cancer survivors. Sci Rep. 2020 Jan 21;10(1):884. (SCI)
   

2. 1. Huang CF, Iio E, Jun DW, Ogawa E, Toyoda H, Hsu YC, Haga H, Iwane S, Enomoto M, Lee DH, Wong G, Liu CH, Tada T, Chuang WL, Cheung R, Hayashi J, Tseng CH, Yasuda S, Tran S, Kam L, Henry L, Jeong JY, Nomura H, Park SH, Nakamuta M, Huang JF, Tai CM, Lo GH, Lee MH, Yang HI, Kao JH, Tamori A, Eguchi Y, Ueno Y, Furusyo N, Tanaka Y, Yu ML, Nguyen MH; REAL-C Investigators. Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium. Hepatol Int. 2019 Sep;13(5):587-598. (SCI)

3. 2. Increase in erosive esophagitis after laparoscopic adjustable gastric banded plication. Tseng CH, Huang CK, Chen TH, Hsu MH, Chen IS, Tai CM(correspondence). Advances in Digestive Medicine 2019;6:69–72.

4. 3. Tai CM, Yen YC, Bair MJ, Tseng CH, Chang TT, Huang CF, Yeh ML, Dai CY, Chuang WL, Yu ML, Huang JF. Integrated care for methadone maintenance patients with hepatitis C virus infection. Kaohsiung J Med Sci. 2019;35(8):501-507.(SCI)

5. Jun T, Hsu YC, Ogawa S, Huang YT, Yeh ML, Tseng CH, Huang CF, Tai CM, Dai CY, Huang JF, Chuang WL, Yu ML, Tanaka Y, Nguyen MH. Mac-2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection. Hepatol Commun. 2019;3:493-503. (SCI)

6. Liu HK, Yang MC, Su YT, Tai CM, Wei YF, Lin IC, Tsai CC. Novel Ultrasonographic Fatty Liver Indicator Can Predict Hepatitis in Children With Non-alcoholic Fatty Liver Disease. Front Pediatr. 2019 Jan 8;6:416. (SCI)

7. Hsu YC, Nguyen MH, Mo LR, Wu MS, Yang TH, Chen CC, Tseng CH, Tai CM, Wu CY, Lin JT, Tanaka Y, Chang CY. Combining hepatitis B core-related and surface antigens at end of nucleos(t)ide analogue treatment to predict off-therapy relapse risk. Aliment Pharmacol Ther. 2019 ;49:107-115. (SCI)

8. Liou JM, Chen PY, Kuo YT, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Toward population specific and personalized treatment of Helicobacter pylori infection. J Biomed Sci. 2018;25:70. (SCI)

9. Tseng CH, Chang CY, Mo LR, Lin JT, Tai CM, Perng DS, Lin CW, Hsu YC. Acoustic Radiation Force Impulse Elastography with APRI and FIB-4 to Identify Significant Liver Fibrosis in Chronic Hepatitis B Patients. Ann Hepatol. 2018;17:789-794. (SCI)

10. Wang WL, Chang IW, Chen CC, Chang CY, Tseng CH, Tai CM, Lin JT, Wang HP, Lee CT. The in vivo tissue effect of endoscopic balloon-based radiofrequency ablation in treating esophageal squamous cell neoplasia. United European Gastroenterol J. 2018;6:656-661. (SCI)

11. Liou JM, Chen PY, Luo JC, Lee JY, Chen CC, Fang YJ, Yang TH, Chang CY, Bair MJ, Chen MJ, Hsu YC, Hsu WF, Chang CC, Lin JT, Shun CT, El-Omar EM, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium. Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection. 2018;155:1109-1119. (SCI)

12. Liou JM, Chen CC, Fang YJ, Chen PY, Chang CY, Chou CK, Chen MJ, Tseng CH, Lee JY, Yang TH, Chiu MC, Yu JJ, Kuo CC, Luo JC, Hsu WF, Hu WH, Tsai MH, Lin JT, Shun CT, Twu G, Lee YC, Bair MJ, Wu MS; Members of the Taiwan Gastrointestinal Disease and Helicobacter Consortium . 14 day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: a multicentre, non-inferiority, randomized trial. J Antimicrob Chemother. 2018;73:2510-2518(SCI)

13. Wang WL, Chang IW, Chen CC, Chang CY, Tseng CH, Tai CM, Lin JT, Wang HP, Lee CT. Lessons from pathological analysis of recurrent early esophageal squamous cell neoplasia after complete endoscopic radiofrequency ablation. 2018;50:743-750. (SCI)

14. Chung CS, Tai CM, Huang TY, Chang CW, Chen KC, Tseng CM, Wang HY, Chu CH, Wu JM, Chen Y, Wang HP. Small bowel tumors: A digestive endoscopy society of Taiwan (DEST) multicenter enteroscopy-based epidemiologic study. J Formos Med Assoc. 2018;117:705-710. (SCI)

15. Lin IC, Tai CM, Tseng CM. Duodenal invasion of hepatocellular carcinoma following transarterial chemoembolization. Dig Liver Dis. 2018;50:618. (SCI)

16. Tsai YN, Wang HP, Huang CK,Chang PC, Lin IC, Tai CM(correspondence). Endoluminal stenting for the management of leak following sleeve gastrectomy and loop duodenojejunal bypass with sleeve gastrectomy. Kaohsiung J Med Sci. 2018;34:43-48. (SCI)

17. Chien NH, Huang YT, Wu CY, Chang CY, Wu MS, Kao JH, Mo LR, Tai CM, Lin CW, Yang TH, Lin JT, Hsu YC. Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy. BMC Gastroenterol.2017;17:154.

18. Hsu YC, Mo LR, Chang CY, Wu MS, Yang TH, Kao JH, Chen CC, Tseng CH, Tai CM, Lin CW, Wu CY, Lin JT. Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy. J Gastroenterol Hepatol. 2017;32:1512-1519 (SCI)

19. Huang JF, Yeh ML, Huang CF, Huang CI, Tsai PC, Tai CM, Yang HL, Dai CY, Hsieh MH, Chen SC, Yu ML, Chuang WL. Cytokeratin-18 and uric acid predicts disease severity in Taiwanese nonalcoholic steatohepatitis patients. PLoS One. 2017;12:e0174394. (SCI)

20. Tai CM, Yu ML, Tu HP, Huang CK, Hwang JC, Chuang WL. Derivation and validation of a scoring system for predicting nonalcoholic steatohepatitis in Taiwanese patients with severe obesity. Surg Obes Relat Dis. 2017;13:686-692. (SCI)

21. ChangPC, Huang CK, Tai CM, et al. Revision using totally hand-sewn gastrojejunostomy and truncal vagotomy for refractory marginal ulcer after laparoscopic roux-en-y gastric bypass: a case series. Surg Obes Relat Dis. 2017;13:588-593. (SCI)

22. ChangPC, Tai CM, Hsin MC et al. Surgical Standardization to Prevent Gastric Stenosis after Laparoscopic Sleeve Gastrectomy: A Case Series. Surg Obes Relat Dis. 2017;13:385-390. (SCI)

23. Tseng CM, Lin IC, Chang CY, Wang HP, Chen CC, Mo LR, Lin JT, Tai CM (correspondence). Role of computed tomography angiography on the management of overt obscure gastrointestinal bleeding. PLoS One. 2017;12:e0172754. (SCI)

24. Chen CC, Hsu YC, Lee CT, Hsu CC, Tai CM, Wang WL, Tseng CH, Hsu CT, Lin JT, Chang CY. Central Obesity and H. pylori Infection Influence Risk of Barrett's Esophagus in an Asian Population. PLoS One.2016;11:e0167815. (SCI)

25. Chang CY, Lee LJ, Wang JD, Lee CT,Tai CM, Tang TQ, Lin JT. Health-related quality of life in patients with Barrett's esophagus. Health-related quality of life 2016;14:158. (SCI)

26. Tseng CM, Tsai JW, Tai CM, Chang CY, Tang TQ, Wang HP. A rare presentation of clinically intractable hypertension: Pancreatic paraganglioma. Advances in Digestive Medicine 2016;3:132-34

27. Fang LH, Chang IW, Tai CM (correspondence). A small esophageal polyp. 2016 ;151:e6-e7 (SCI)

28. Chen IS, Chuang HW, Tai CM (correspondence). Ileal Dieulafoy's lesion presenting as a bleeding submucosal tumor. J Gastroenterol Hepatol. 2016;31:1914. (SCI)

29. Huang CK, Tai CM, Chang PC, Malapan K, Tsai CC, Yolsuriyanwong K. Loop Duodenojejunal Bypass with Sleeve Gastrectomy: Comparative Study with Roux-en-Y Gastric Bypass in Type 2 Diabetic Patients with a BMI <35 kg/m2, First Year Results. Obes Surg. 2016;26:2291-301. (SCI)

30. Hsu MH, Chang IW, Tai CM (correspondence). White Spots at the Rectum. Gastroenterology. 2016;151:e15-6. (SCI)

31. Tai CM, Huang CK, Tu HP, Hwang JC, Yeh ML, Huang CF, Huang JF, Dai CY, Chuang WL, Yu ML. Interactions of a PPARGC1A Variant and a PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients. Medicine (Baltimore). 2016;95:e3120. (SCI)

32. Chang PC, Dev A, Katakwar A, Hsin MC, Tai CM, Huang CK. Management of gastric fold herniation after laparoscopic adjustable gastric banded plication: a single-center experience. Surg Obes Relat Dis. 2016;12:849-55. (SCI)

33. Tseng CM, Su YC, Tai CM (correspondence). An Unusual Cause of Obscure Gastrointestinal Bleeding. 2016;150:e9-10 (SCI)

34. Tseng CM, Chuang HW, Tai CM (correspondence). Gastrointestinal: Duodenal metastatic epithelioid angiosarcoma. J Gastroenterol Hepatol. 2016;31:705

35. Chen TH, Chen YJ, Tai CM (correspondence) . An unusual cause of GI bleeding. 2016 ;65:1099. (SCI)

36. Ahluwalia JS, Chang PC, Tai CM, Tsai CC, Sun PL, Huang CK. Comparative Study Between Laparoscopic Adjustable Gastric Banded Plication and Sleeve Gastrectomy in Moderate Obesity-2 Year Results. Obes Surg. 2016;26:552-7 (SCI)

37. Tsai YN, Tsai JW, Tai CM (correspondence). Education and Imaging. Gastrointestinal: Magnifying endoscopy for pseudomelanosis duodeni. J Gastroenterol Hepatol. 2016;31:520. (SCI)

會議報告:

1. Endoscopic management of complications after bariatric and metabolic surgery, DEST 2017, Taipei

2. Endoscopic Bariatric Therapies, National Academic Conference of Digestive Endoscopology, 2017, HangZhou

3. Orbera balloon for the management of obesity, 2017, 艾爾伯消化內鏡微創切除新技術論壇, HangZhou

4. Recent advances in endoscopic treatment of obesity, 2017,特種消化內鏡診療研討會, Ningbo, Zhejiang

5. Impact of Integrated Care for Hepatitis C Virus-Infected Methadone Maintenance Patients, Taiwan Digestive Disease Week, 2016, Taipei

6. Role of computed tomography angiography before enteroscopy on the management of overt obscure gastrointestinal bleeding (poster presentation), Asia Pacific Digestive Week, 2016, Kobe

7. Impact of Integrated Care for Hepatitis C Virus-Infected Methadone Maintenance Patients (poster presentation), Asian Pacific Association for the Study of the Liver Single Topic Conference, 2016, Kaohsiung

8. Derivation And Validation of A Scoring System for Predicting Nonalcoholic Steatohepatitis in Severely Obese Asians (poster presentation), Asian Pacific Association for the Study of the Liver Single Topic Conference, 2016, Kaohsiung

9. Interactions of A PPARGC1A Variant And A PNPLA3 Variant Affect Nonalcoholic Steatohepatitis in Severely Obese Taiwanese Patients (poster presentation), Asian Pacific Association for the Study of the Liver Single Topic Conference, 2016, Kaohsiung

10. Advance in research in metabolic surgery, 消化醫學學門規劃研究推動成果發表會- Ministry of Science and Technology, 2015, Taichung

11. Sleeve gastrectomy, Friend of GERD, Taiwan Surgical Society of Gastroenterology, 2015, Kaohsiung

12. Alternative ways for weight loss—Gastroenterologist’s view, Dr. TY Lin’s Medical Research Foundation International Surgical Forum 2015, Yilan

13. Endoscopic management of obesity, Obesity and metabolic syndrome workshop, 2015, Taichung

14. Increase in serum HBV DNA level in HBeAg-seronegative obese patients after bariatric surgery (poster presentation), Taiwan Digestive Disease Week 2014, Kaohsiung

15. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease (poster presentation), Taiwan Digestive Disease Week 2014, Kaohsiung

16. Endoluminal stenting for the management of leak following bariatric surgery (poster presentation), Taiwan Digestive Disease Week 2014, Kaohsiung

17. The change of erosive esophagitis after laparoscopic adjustable gastric banded plication and laparoscopic sleeve gastrectomy A case-matched comparison study (poster presentation), Taiwan Digestive Disease Week 2014, Kaohsiung

18. Increase in gastroesophageal reflux disease one year after laparoscopic sleeve gastrectomy among obese adults, IFSO-APC 2013, Kaohsiumg

19. Management of complications after bariatric surgery- the role of endoscopists, IFSO-APC 2013, Kaohsiumg

20. The role of psychiatrists in GI and liver diseases,高屏地區精神醫療學術研討雙 月會, 2012, Kaohsiung

21. Management of GI complications after bariatric surgery, 2012, Beijing

22. Management of the Metabolic/Bariatric Surgery Patients- Role of the Internist, Taiwan Digestive Disease Week 2012, Taipei, Taiwan

23. Increase of gastroesophageal reflux disease after laparoscopic sleeve gastrectomy for obesity (poster presentation), Digestive Disease Week 2011, Chicago

24. Updating Psychiatric Service for Bariatric Patients- Medical Treatment and Intragastric Balloon for Obesity, World Psychiatric Association Regional Meeting, 2011 , Kaohsiung

25. Change of GERD after bariatric surgery. IFSO-Taiwan Chapter, 2011, Taipei

26. Improvement of Nonalcoholic Fatty Liver Disease after Bariatric Surgery in Morbidly Obese Chinese Patients (poster presentation) , The Annual Meeting of GEST, 2010, Taipei